Moreover, we demonstrate that mice derived from crosses between these overexpressors and those carrying a GFAP-driven constitutively active EGFR variant transgene harbor more aggressive, higher-grade gliomas consistent with hyperactivated mTORC2 signaling. The gene discussed is EGFR; the disease is central nervous system cancer.